Cutaneous lupus erythematosus is a chronic autoimmune disease with few treatment options and no approved targeted therapies.
The FDA grants Fast Track designation to nipocalimab for systemic lupus erythematosus following positive results from the phase 2b JASMINE trial.
Johnson & Johnson's nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential ...
Hosted on MSN
13 warning signs of lupus that often go unnoticed
This explainer details common lupus warning signs and why early recognition matters for clinical assessment. It outlines lupus symptoms such as photosensitivity associated with rashes, low-grade fever ...
Dec. 18, 2025 -- At least 1.5 million people in the United States are living with lupus, a chronic and often misunderstood autoimmune disease. What are the most common myths about lupus – and who does ...
About 5 million people worldwide live with the autoimmune condition lupus. This condition can cause a range of symptoms, including tiredness, fever, joint pain and a characteristic butterfly-shaped ...
A doctor advising … sleepaway camp? That’s how a 12-year-old diagnosed with lupus found himself laughing on a high-ropes course as fellow campers hoisted him into the air. “It’s really fun,” said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results